Evaluation of an Interactive E-learning Environment to Enhance Digital Health Literacy in Cancer Patients
Development and Effectiveness Evaluation of an Interactive E-learning Environment to Enhance Digital Health Literacy in Cancer Patients: Study Protocol for a Randomized Controlled Trial
1 other identifier
interventional
660
1 country
1
Brief Summary
This study aims to create and test an online learning tool to help people with cancer improve their skills in finding and understanding health information online. The main question it aims to answer is:
- Do people with cancer who use the online learning tool improve their skills more than those who don't use the tool? The investigators will test this idea in a study. The investigators will put people into different groups by chance and compare the results. 660 people with cancer will participate. These people will be chosen to represent different types of cancer.
- Group 1: Uses the online learning too (3 versions)
- Group 2: Uses a PDF with the same information
- Control Group: Receives no intervention What Participants Will Do: Use the online tool or PDF to learn how to find reliable cancer information online. Answer questions about their digital health skills before starting, after 2 weeks, and after 8 weeks. Development: Before the start of the main study the online tool will be developed and tested. The investigators will first show a prototype of the tool to two discussion groups and use their feedback to improve it. Then, experts and people with cancer will test the final version
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 30, 2024
CompletedStudy Start
First participant enrolled
January 16, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2025
CompletedFirst Posted
Study publicly available on registry
October 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2025
CompletedOctober 1, 2025
September 1, 2025
8 months
July 30, 2024
September 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline in the patient-reported digital health literacy measured by the Digital health literacy Instrument (DHLI) at 8 weeks
The primary outcome is the patient-reported digital health literacy based on the German version of the Digital health literacy Instrument (DHLI), resulting from the mean of the 21 items included. All 21 items are answered on a four-point scale (1="very difficult" to 4="very easy" and from 1="never" to 4="often"). A higher mean score indicates higher digital health literacy.
The questionnaire will be administered at baseline (TO), follow-up at 2 weeks (T1), and follow-up at 8 weeks (T8).
Secondary Outcomes (5)
Digital health literacy measured with the performance-based items of the DHLI
The questionnaire will be administered at baseline (TO), follow-up at 2 weeks (T1), and follow-up at 8 weeks (T8).
Participants' motivation to use the e-learning environment measured with the Reduced Instructional Materials Motivation (RIMMS)
The questionnaire will be administered at follow-up at 2 weeks (T1).
Acceptability of the e-learning environment as measured by the Acceptability of Intervention Measure (AIM) questionnaire.
The questionnaire will be administered at follow-up at 2 weeks (T1).
Appropriateness of the e-learning environment as measured by the Intervention Appropriateness Measure (IAM) questionnaire.
The questionnaire will be administered at follow-up at 2 weeks (T1).
Feasibility of the e-learning environment as measured by the Feasibility of Intervention Measure (FIM) questionnaire.
The questionnaire will be administered at follow-up at 2 weeks (T1).
Study Arms (5)
e-learning - intervention group 1.1
EXPERIMENTALParticipants in intervention group 1.1 will be given access to an e-learning environment with all the persuasive primary task support elements (reduction, tunneling, rehearsal). Participants can complete the e-learning within 2 weeks. The e-learning program takes approximately 20-45 minutes to complete.
e-learning - intervention-group 1.2
EXPERIMENTALParticipants in intervention group 1.2 are given access to the same e-learning environment without the persuasive primary task support element, tunneling. Tunneling means that the educational content is organized step by step in separate chapters of the program. Participants can complete the e-learning within 2 weeks. The e-learning program takes approximately 20-45 minutes to complete.
e-learning - intervention-group 1.3
EXPERIMENTALParticipants in intervention group 1.3 are given access to the same e-learning environment without the persuasive primary task support element, rehearsal. All rehearsal elements such as quizzes will be removed from the e-learning environment. Participants can complete the e-learning within 2 weeks. The e-learning program takes approximately 20-45 minutes to complete.
PDF document - intervention-group 2
ACTIVE COMPARATORThis intervention group is given access to a PDF document with the same content as in the e-learning environment. Participants can complete the website content within 2 weeks. The PDF document takes approximately 20-45 minutes to complete.
No Intervention/ treatment as usual
NO INTERVENTIONThe last group (treatment as usual) receives no intervention. However, they are sent a brochure that has nothing to do with digital health literacy.
Interventions
The e-learning environment will include text, images, and short videos created using Articulate Rise 360, an easy-to-use e-learning authoring tool, with the following content to improve the different skills of digital health literacy: 1. Evaluating reliability skills: Participants will get to know criteria and indicators for evaluating the content of the information they find and for assessing the trustworthiness of website providers. 2. Improving information skills: Participants will learn simple rules on how to optimize their Google searches. 3. Improving navigation skills: Participants will learn simple rules for navigation; using the back button; using more than one tab; drop-down lists and anchor links are introduced. 4. Additional goals are to raise awareness about various aspects related to online searches, including the exploration of alternative and complementary therapies, and the importance of data protection.
Participants are also given access to the e-learning environment. However, they will not be taken step-by-step through the content (tunneling). They can choose the order of the content.
Participants are also given access to the e-learning environment, but all rehearsal elements such as quizzes will be removed from the e-learning environment.
Participants in IG2 will receive the same content as participants in the IG1.1, but not within the interactive learning environment, but in a non-interactive PDF format.
Eligibility Criteria
You may qualify if:
- cancer diagnosis
- sufficient knowledge of the German language as all study content and questionnaires will be in German only
- Participants must also have and be able to use a digital device (smartphone, tablet, PC, laptop, etc.) with an internet connection
- Confirm consent to participate in the study
You may not qualify if:
- Patients who are severely cognitively impaired due to their cancer or other illness
- Patients who are unable to operate a digital device
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Medical Center Hamburg-Eppendorf
Hamburg, Hamburg, 20246, Germany
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Holger Schulz, Prof.
Universitätsklinikum Hamburg-Eppendorf
- PRINCIPAL INVESTIGATOR
Susanne Weg-Remers, Dr.
German Cancer Research Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Blinding will be maintained throughout the duration of the study to increase the objectivity of the results and to minimize the influence of participants' expectations on the study results. Participants in the control group will not receive any intervention and will be referred to the CIS brochure "Your journey through cancer", which will not include any information on how to search for cancer-related information online. In the dataset and in REDCap, the 5 randomization groups are referred to as groups A, B, C, D and E, so that it is not clear to the research staff evaluating the data which intervention the patients received.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 30, 2024
First Posted
October 1, 2025
Study Start
January 16, 2025
Primary Completion
September 1, 2025
Study Completion
October 1, 2025
Last Updated
October 1, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- SAP
- Time Frame
- The data will be available a few days before the study results are released.
- Access Criteria
- Figshare uses Creative Commons licenses, which give other researchers the right to use and build upon a dataset.
* The study protocol was submitted to Frontiers in Public Health on June 24, 2024. * The statistical analysis plan will be uploaded prior to unblinding for data analysis. * The study data will be made available to other scientists via the online open access repository Figshare (https://figshare.com/) Figshare uses Creative Commons licenses, which give other researchers the right to use and build upon a dataset.